SEC Filings
Winnebago Ends Vision One Fight, Adds Lamar's CFO To Board And Moves To Scrap Staggered Terms
The cooperation deal pulls Vision One's director slate and sends a three-year phase-out of the classified board to a shareholder vote.
SEC Filings
The cooperation deal pulls Vision One's director slate and sends a three-year phase-out of the classified board to a shareholder vote.
SEC Filings
The drugmaker presented Phase 1b data at ESMO and said FDA talks cleared the design of its Redwood-1 trial.
SEC Filings
Seshadri joins the payments company's board November 30, while De Castro will not seek re-election at the 2027 annual meeting.
SEC Filings
The oilfield services company grew in every region from the prior quarter, and its CEO sees a "very compelling outlook for 2027."
SEC Filings
The hard-drive maker now credits end buyers, not distributors, while buybacks and convertible-note settlements drained cash and lifted revolver debt.
SEC Filings
Cash fell by $3.1 billion in nine months as the ad giant paid for repurchases and dividends with its balance sheet and new debt.
SEC Filings
The new repurchase starts the London business day after the current program finishes and must end by 16 April 2027, with all shares cancelled.
SEC Filings
The title insurer's 10-Q shows a six-year secured note to an affiliate, plus $405.1 million of venture-book losses against $280.8 million of gains.
SEC Filings
The biotech plans a front-line Phase 3 trial in the first half of 2027 while narrowing its research to PRMT5 drugs.
SEC Filings
The Raleigh bank also bought back $600 million of stock, prepaid $8.0 billion of its FDIC note and authorized $1.2 billion of buybacks for 2027.
SEC Filings
Zymeworks could collect up to $718 million more in milestones, plus royalties, if the deal clears U.S. antitrust review.
SEC Filings
The airbag and seatbelt maker kept its sales and cash flow outlook, but cost pressure pushed margin guidance to the bottom of its prior range.